Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Burden

Showing results (71-80 of 83) with videos related to

Pageof 9
Sort By:
Clinical and Translational Science|April 30, 2026
Evaluation of a Therapeutic Drug Monitoring Strategy for Adalimumab in Psoriasis: A Prospective Pharmacokinetic-Pharmacodynamic StudyShan Pan, Teresa Tsakok, Ruoheng Wei, et al.
Clinical and Translational Science|January 30, 2020
Using Real-World Data to Guide Ustekinumab Dosing Strategies for Psoriasis: A Prospective Pharmacokinetic-Pharmacodynamic StudyShan Pan, Teresa Tsakok, Nick Dand, et al.
The Journal of Allergy and Clinical Immunology|December 23, 2018
HLA-C*06:02 genotype is a predictive biomarker of biologic treatment response in psoriasisNick Dand, Michael Duckworth, David Baudry, et al.
The Journal of Allergy and Clinical Immunology|May 30, 2024
A genome-wide meta-analysis of palmoplantar pustulosis implicates T<sub>H</sub>2 responses and cigarette smoking in disease pathogenesisAriana Hernandez-Cordero, Laurent Thomas, Alice Smail, et al.
JCI Insight|February 22, 2023
Development of antidrug antibodies against adalimumab maps to variation within the HLA-DR peptide-binding grooveTeresa Tsakok, Jake Saklatvala, Theo Rispens, et al.
The Journal of Investigative Dermatology|July 9, 2016
AP1S3 Mutations Cause Skin Autoinflammation by Disrupting Keratinocyte Autophagy and Up-Regulating IL-36 ProductionSatveer K Mahil, Sophie Twelves, Katalin Farkas, et al.
JAMA Dermatology|September 16, 2020
Association of Clinical and Demographic Factors With the Severity of Palmoplantar PustulosisNatashia Benzian-Olsson, Nick Dand, Charlotte Chaloner, et al.
The Journal of Allergy and Clinical Immunology|July 24, 2018
Clinical and genetic differences between pustular psoriasis subtypesSophie Twelves, Alshimaa Mostafa, Nick Dand, et al.
JAMA Dermatology|May 1, 2024
International Consensus Definition and Diagnostic Criteria for Generalized Pustular Psoriasis From the International Psoriasis CouncilSiew Eng Choon, Peter van de Kerkhof, Johann E Gudjonsson, et al.
The Journal of Investigative Dermatology|November 26, 2010
Meta-analysis confirms the LCE3C_LCE3B deletion as a risk factor for psoriasis in several ethnic groups and finds interaction with HLA-Cw6Eva Riveira-Munoz, Su-Min He, Georgia Escaramís, et al.
Pageof 9

Showing results (71-80 of 83) with videos related to

Sort By:
Pageof 9
Clinical and Translational Science|April 30, 2026
Evaluation of a Therapeutic Drug Monitoring Strategy for Adalimumab in Psoriasis: A Prospective Pharmacokinetic-Pharmacodynamic StudyShan Pan, Teresa Tsakok, Ruoheng Wei, et al.
Clinical and Translational Science|January 30, 2020
Using Real-World Data to Guide Ustekinumab Dosing Strategies for Psoriasis: A Prospective Pharmacokinetic-Pharmacodynamic StudyShan Pan, Teresa Tsakok, Nick Dand, et al.
The Journal of Allergy and Clinical Immunology|December 23, 2018
HLA-C*06:02 genotype is a predictive biomarker of biologic treatment response in psoriasisNick Dand, Michael Duckworth, David Baudry, et al.
The Journal of Allergy and Clinical Immunology|May 30, 2024
A genome-wide meta-analysis of palmoplantar pustulosis implicates T<sub>H</sub>2 responses and cigarette smoking in disease pathogenesisAriana Hernandez-Cordero, Laurent Thomas, Alice Smail, et al.
JCI Insight|February 22, 2023
Development of antidrug antibodies against adalimumab maps to variation within the HLA-DR peptide-binding grooveTeresa Tsakok, Jake Saklatvala, Theo Rispens, et al.
The Journal of Investigative Dermatology|July 9, 2016
AP1S3 Mutations Cause Skin Autoinflammation by Disrupting Keratinocyte Autophagy and Up-Regulating IL-36 ProductionSatveer K Mahil, Sophie Twelves, Katalin Farkas, et al.
JAMA Dermatology|September 16, 2020
Association of Clinical and Demographic Factors With the Severity of Palmoplantar PustulosisNatashia Benzian-Olsson, Nick Dand, Charlotte Chaloner, et al.
The Journal of Allergy and Clinical Immunology|July 24, 2018
Clinical and genetic differences between pustular psoriasis subtypesSophie Twelves, Alshimaa Mostafa, Nick Dand, et al.
JAMA Dermatology|May 1, 2024
International Consensus Definition and Diagnostic Criteria for Generalized Pustular Psoriasis From the International Psoriasis CouncilSiew Eng Choon, Peter van de Kerkhof, Johann E Gudjonsson, et al.
The Journal of Investigative Dermatology|November 26, 2010
Meta-analysis confirms the LCE3C_LCE3B deletion as a risk factor for psoriasis in several ethnic groups and finds interaction with HLA-Cw6Eva Riveira-Munoz, Su-Min He, Georgia Escaramís, et al.
Pageof 9